Prior work has demonstrated that the treatment with recombinant human TNF-α in a B16F10 melanoma mouse model of lung metastasis increased tumor burden and metastatic foci and was associated with increased numbers of pulmonary regulatory CD4+/Foxp3+ T cells. This evidence concerns the gene CD4 and neoplasm.